Practical considerations in utilizing cluster randomized controlled trials conducted in biopharmaceutical industry

Yixin Fang,Weili He
DOI: https://doi.org/10.1177/17407745211073484
2022-03-05
Clinical Trials
Abstract:Cluster randomized controlled trials (cluster RCTs), also known as parallel-arm group-randomized trials, are trials in which the randomized units are groups of participants, as opposed to individual participants. These trials have largely been implemented to address broad public health issues, but with the growing interest in use of real-world data in the regulatory setting, this design may be increasingly considered for industry trials. The key difference between cluster RCTs and traditional RCTs is the intraclass correlation coefficient (ICC) that needs to be considered in cluster RCTs. In this article, we discuss some key practical considerations that are related to ICC in the design, conduct, analysis, and report stages of a cluster RCT. These key considerations related to ICC can lead to improvement in how we translate research findings from cluster RCTs into practices in the biopharmaceutical industry.
medicine, research & experimental
What problem does this paper attempt to address?